Parallel Bio

Drug DiscoveryWebsite
Current Valuation
$71.5M
As of June 12, 2025
Total Funding Raised
$24.6M
Across 2 rounds
Last Round
Later Stage VC

$20.0M

Last Funding
Jun 2025

Funding date

Capital Efficiency
2.90x

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
DateRoundAmountPost-ValuationGrowth
June 12, 2025Later Stage VC (Series A1)$20.0MN/A-
December 20, 2022Seed Round$4.3MN/A-
Valuation Analysis

Current Valuation Metrics

Parallel Bio is currently valued at $71.5M as of June 12, 2025. The company has raised a total of $24.6M in funding across 2 funding rounds.

Capital Efficiency

With a capital efficiency ratio of 2.90x, Parallel Bio has achieved a valuation that is 2.90 times the total capital raised.

Track Parallel Bio Valuation Updates

Get notified when Parallel Bio raises new funding or valuation changes

Explore More Data
Detailed analysis for Parallel Bio

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Parallel Bio's valuation history, funding rounds, and growth metrics.

No credit card required

What is Parallel Bio Worth in 2026?

Parallel Bio is a leading private company in the Drug Discovery sector. Track Parallel Bio's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Parallel Bio Valuation is Determined

Private company valuations like Parallel Bio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.